Abstract
BackgroundFor treatment of neovascular age-related macular degeneration (nAMD), multiple intravitreal injections of drugs targeting vascular endothelial growth factors (VEGF) result in a high burden for patients and healthcare systems. Low-energy...
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have